Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
9 Patents
#68 in Lexington, MA
#1,926 in Massachusetts
#32,605 in US
Pulmatrix, Inc.
Forward Citations = 77
11 inventors:
Lexington, MA, United States of America
Pulmatrix, Inc.
% Expired Patents = 11.1
CIPO Patents = 1
EPO Patents = 3
Forward Citations = 77
Loading Chart...
Loading Chart...
11 inventors (with patents filed for the assignee):
Jean C Sung (6 out of 17 patents)
Michael M Lipp (6 out of 31 patents)
Robert William Clarke (4 out of 6 patents)
4. David A Edwards (3 out of 79 patents)
5. Jonathan Chun-Wah Man (2 out of 2 patents)
6. Jeffrey P Katstra (2 out of 2 patents)
7. Wesley H DeHaan (1 out of 4 patents)
8. David L Hava (1 out of 2 patents)
9. Mark J Gabrielson (1 out of 1 patent)
10. Matthew Frederick Brande (1 out of 1 patent)
11. Jonathan C Man (1 out of 1 patent)
12. Richard Batycky (0 patent)
13. John Hanrahan (0 patent)
9 patents:
5. 8992983 - Respirably dry powder comprising calcium lactate, sodium chloride and leucine (2015-03-31),
Company Overview
Pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious respiratory diseases. Their proprietary iSPERSE technology enables the delivery of small molecules, biologics, and nucleic acids to the lungs in a precise and controlled manner. Pulmatrix is focused on improving the lives of patients with conditions such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pulmatrix, Inc.. Retrieved from https://idiyas.com/company/pulmatrix
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]